Probmet Therapeutics logo

Probmet Therapeutics

An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients.

2 employees · est. 2022 · Denmark

VS
Werewolf Therapeutics logo

Werewolf Therapeutics

Advancing a pipeline of next generation, transformative immuno-stimulatory medicines for cancer patients.

27 employees · est. 2017 · Watertown, United States

Werewolf Therapeutics is the older company (2022 vs 2017); Werewolf Therapeutics is the larger of the two.

Side-by-Side Comparison

Probmet Therapeutics Werewolf Therapeutics
Founded
2022 2017 older
Headquarters
Denmark Watertown, United States
Employees
2 27 larger
Industry
Health Care, Health and Wellness Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Convertible Note Post Ipo Secondary
Total Funding
$500.00K $178.17M
Funding Rounds
1 3
Services
Targeted Cancer Treatments, Drug Discovery and Development, Clinical Trial Research, Biomarker Strategy Not tracked yet
Target Customers
Breast Cancer Patients with Brain Metastasis, Oncologists and Clinical Researchers, Pharmaceutical and Biotech Companies Not tracked yet
Taxonomy
Oncology Therapeutics, Targeted Treatments, Breast Cancer, Brain Metastasis, Precision Medicine, Metastatic Cancer, Therapeutic Development, Innovation In Cancer Treatment, Breakthrough Therapies, Neuroscience Oncology, Cancer Research, Pharmaceuticals Immuno-oncology, Biopharmaceutical, Therapeutics, Cancer Treatments, Immune System Stimulation, Oncology, Biopharma Innovation, Cancer Therapeutics, Immunotherapy, Transformative Medicines
Website
probmet.com werewolftx.com
Probmet Therapeutics logo

About Probmet Therapeutics

Probmet Therapeutics, headquartered in Denmark, is making strides in the field of precision oncology with a focus on developing new therapies for metastatic breast cancer in the brain. Founded in 2022, the company operates within the Health Care and Health and Wellness industries. Its core mission r...

Werewolf Therapeutics logo

About Werewolf Therapeutics

Werewolf Therapeutics is a biotechnology startup, founded in 2017 and based in the United States. The company is driven by the mission of advancing a pipeline of next-generation, transformative immuno-stimulatory medicines for cancer patients. Their slogan, "Advancing a pipeline of next generation,...

We will tell you when either one moves

BounceWatch watches Probmet Therapeutics and Werewolf Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Probmet Therapeutics and Werewolf Therapeutics — by email.

Frequently Asked Questions

Probmet Therapeutics — An oncology therapeutics company developing new targeted treatments for breast cancer brain metastatic patients. . Werewolf Therapeutics — Advancing a pipeline of next generation, transformative immuno-stimulatory medicines for cancer patients.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Probmet Therapeutics has raised $500.00K while Werewolf Therapeutics has raised $178.17M.
Probmet Therapeutics and Werewolf Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Probmet Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Probmet Therapeutics on 14 Mar 2026, and Werewolf Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy